Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2009-01-23
Original market date: See footnote 1
2003-02-11
Product name:
REFACTO
DIN:
02245951 Electronic product monograph is not available
Company:
WYETH CANADA
1025 Boulevard Marcel Laurin
St. Laurent
Quebec
Canada
H4R 1J6
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Schedule D
American Hospital Formulary Service (AHFS): See footnote 3
20:28.16
Anatomical Therapeutic Chemical (ATC): See footnote 4
B02BD02 COAGULATION FACTOR VIII
Active ingredient group (AIG) number:See footnote5
0147521001
Active ingredient(s) | Strength |
---|---|
MOROCTOCOG ALFA | 1000 UNIT / VIAL |